Rohr UP - Search Results

1

Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.

Ghosh P, Tie J, Muranyi A, Singh S, Brunhoeber P, Leith K, Bowermaster R, Liao Z, Zhu Y, LaFleur B, Tran B, Desai J, Jones I, Croxford M, Jover R, Goel A, Waring P, Hu S, Teichgraber V, Rohr UP, Ridder R, Shanmugam K, Gibbs P. Ghosh P, et al. Among authors: rohr up. Clin Cancer Res. 2016 Jul 15;22(14):3488-98. doi: 10.1158/1078-0432.CCR-15-2290. Epub 2016 Mar 30. Clin Cancer Res. 2016. PMID: 27029492 Free PMC article.

2

Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests.

Vyberg M, Nielsen S, Røge R, Sheppard B, Ranger-Moore J, Walk E, Gartemann J, Rohr UP, Teichgräber V. Vyberg M, et al. Among authors: rohr up. BMC Health Serv Res. 2015 Aug 29;15:352. doi: 10.1186/s12913-015-1018-6. BMC Health Serv Res. 2015. PMID: 26318869 Free PMC article.

3

Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Geddert H, Pflugfelder L, Bruns I, Neukirch J, Rohrbeck A, Grote HJ, Steidl U, Fenk R, Opalka B, Gabbert HE, Kronenwett R, Haas R. Rohr UP, et al. Clin Cancer Res. 2005 Jan 1;11(1):180-5. Clin Cancer Res. 2005. PMID: 15671544

4

FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non-Small Cell Lung Cancer, a Collaborative Project Orbis Review.

Koch AL, Vellanki PJ, Drezner N, Li X, Mishra-Kalyani PS, Shen YL, Xia H, Li Y, Liu J, Zirkelbach JF, Palazov E, Gamarian A, Choo Q, Girčys A, Rohr UP, Fesenko N, Spillman D, Pazdur R, Beaver JA, Singh H. Koch AL, et al. Among authors: rohr up. Clin Cancer Res. 2021 Dec 15;27(24):6638-6643. doi: 10.1158/1078-0432.CCR-21-1034. Epub 2021 Jul 22. Clin Cancer Res. 2021. PMID: 34301748 Clinical Trial.

5

Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies.

Cassidy J, Saltz LB, Giantonio BJ, Kabbinavar FF, Hurwitz HI, Rohr UP. Cassidy J, et al. Among authors: rohr up. J Cancer Res Clin Oncol. 2010 May;136(5):737-43. doi: 10.1007/s00432-009-0712-3. Epub 2009 Nov 11. J Cancer Res Clin Oncol. 2010. PMID: 19904559 Free PMC article.

6

Expression of the tyrosine kinase c-kit is an independent prognostic factor in patients with small cell lung cancer.

Rohr UP, Rehfeld N, Pflugfelder L, Geddert H, Müller W, Steidl U, Fenk R, Gräf T, Schott M, Thiele KP, Gabbert HE, Germing U, Kronenwett R, Haas R. Rohr UP, et al. Int J Cancer. 2004 Aug 20;111(2):259-63. doi: 10.1002/ijc.20252. Int J Cancer. 2004. PMID: 15197780 Free article.

7

Project Orbis: Global Collaborative Review Program.

de Claro RA, Spillman D, Hotaki LT, Shum M, Mouawad LS, Santos GML, Robinson K, Hunt M, Healy C, Chan A, Looi YH, Rodrigues C, Rohr UP, Walther C, Pazdur R. de Claro RA, et al. Among authors: rohr up. Clin Cancer Res. 2020 Dec 15;26(24):6412-6416. doi: 10.1158/1078-0432.CCR-20-3292. Epub 2020 Oct 9. Clin Cancer Res. 2020. PMID: 33037016

8

Bevacizumab safety in patients with central nervous system metastases.

Besse B, Lasserre SF, Compton P, Huang J, Augustus S, Rohr UP. Besse B, et al. Among authors: rohr up. Clin Cancer Res. 2010 Jan 1;16(1):269-78. doi: 10.1158/1078-0432.CCR-09-2439. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028762

9

The influence of the pituitary tumor transforming gene-1 (PTTG-1) on survival of patients with small cell lung cancer and non-small cell lung cancer.

Rehfeld N, Geddert H, Atamna A, Rohrbeck A, Garcia G, Kliszewski S, Neukirchen J, Bruns I, Steidl U, Fenk R, Gabbert HE, Kronenwett R, Haas R, Rohr UP. Rehfeld N, et al. Among authors: rohr up. J Carcinog. 2006 Jan 20;5:4. doi: 10.1186/1477-3163-5-4. J Carcinog. 2006. PMID: 16426442 Free PMC article.

10

Coexpression of fragile histidine triad and c-kit is relevant for prediction of survival in patients with small cell lung cancer.

Rehfeld N, Geddert H, Atamna A, Gabbert HE, Steidl U, Fenk R, Kronenwett R, Haas R, Rohr UP. Rehfeld N, et al. Among authors: rohr up. Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2232-8. doi: 10.1158/1055-9965.EPI-06-0342. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17119051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page